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osting by EAbstract Pigmenting pityriasis alba is a rare variant of pityriasis alba. We present a 10-year-old
Saudi girl with multiple hypopigmented scaly patches with central bluish hyperpigmentation over
the face of one year duration. Histological examination revealed features of pigmenting pityriasis
alba. The condition was not associated with dermatophyte infection or classic pityriasis alba.
Twelve-week course of 1% hydrocortisone cream resulted in clearance of the lesions.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Pigmenting pityriasis alba (PPA) is a rare, perhaps under
-reported variant of pityriasis alba (PA). It is characterized
by hyperpigmented bluish scaly patches surrounded by hypo-
pigmented halo affecting mostly the face. Although, initially
it has been described in the cape-colored population of South
Africa, subsequent cases have been reported from other coun-
tries (du Toit and Jordaan, 1993; Dhar et al., 1995). Associa-
tion with classic PA and dermatophyte infection has beeny, College of Medicine, King
University, P.O. Box 240997,
mail.com
y. Production and hosting by
Saud University.
lsevierreported (du Toit and Jordaan, 1993). We report a case of
PPA from the middle east.
2. Case report
A 10-year-old Saudi girl, presents to the dermatology clinic in
King Fahad National Guard Hospital with asymptomatic
scaly hypopigmented patches with central bluish pigmentation
on the face of one year duration. The lesions started small in
size and then increased gradually. There is no family history
of the same condition and there is no personal or family his-
tory of atopy. The past medical, surgical, and drug histories
were insigniﬁcant.
Cutaneous examination revealed well-demarcated bluish
hyperpigmented scaly patches measuring 2 · 2 cm on the
cheeks and forehead surrounded by a hypopigmented halo
3 cm in diameter (Fig. 1). There was no sensory deﬁcit over
the lesions. The rest of the cutaneous and systemic examina-
tions were unremarkable. Woods light examination showed a
hypopigmented halo.
All blood tests including complete blood count, liver func-
tion test, renal function test, antinuclear antibodies (ANA),
anti-double strand DNA antibodies, rheumatoid factor were
Figure 1 Well-demarcated hypopigmented patches with bluish
center affecting the cheeks and the forehead.
32 M.A. AlShahwannegative. Scraping for KOH examination and culture did not
reveal any dermatophyte.
Histopathological examination of the skin from the center
of the lesion showed mild acanthosis, focal spongiosis, and a
sparse upper dermal perivascular lymphomononuclear inﬁl-
trate with pigment incontinence (Fig. 2).
The patient was started on 1% hydrocortisone cream twice
daily and on eight weeks follow-up, she showed 70% improve-
ment with almost complete clearance after a 12-week treatment
course without any noticeable side effects of the treatment.
3. Discussion
PA is a common skin condition, affecting between 1.9% and
5.25% of preadolescent children (Vanderhooft et al., 1996;
Nanda et al., 1999; Inanir et al., 2002; Fung and Lo, 2000;
Popescu et al., 1999). It is found in all parts of the worldFigure 2 Histopathology of the lesion shows mild acanthosis,
focal spongiosis, and a sparse upper dermal perivascular lympho-
mononuclear inﬁltrate with pigment incontinence (hematoxylin
and eosin. Original magniﬁcation ·100).and does not have any gender predisposition (Vanderhooft
et al., 1996; Nanda et al., 1999; Inanir et al., 2002; Wells
et al., 1960; O’Farrell, 1956).
In 1993, Du Toit et al. describe a series of 20 patients from
the cape colored population (non-caucasian) with an uncom-
mon variant of PA, occurring in childhood. They called it –
Pigmenting Pityriasis Alba (PPA). Later, an additional report
followed from India describing a similar condition (Dhar et al.,
1995). Our patient is the ﬁrst case of PPA reported from the
Middle East.
PA is a condition of unknown etiology (du Toit and Jordaan,
1993). It is best characterized as a form of dermatitis that results
in the reduction of melanocytes and melanosomes with no
detectable defect in melanosomal transfer to keratinocytes
(Nanda et al., 1999; Wells et al., 1960; Pinto and Bolognia,
1991). Bacterial, fungal, and parasitic infections are more fre-
quent among PA patients but no deﬁnitive association has been
found (Galan and Janniger, 1998; Bassaly et al., 1963). Other
possible causes include copper deﬁciency (tyrosinase cofactor)
(Galadari et al., 1992), physical factors that affect the state of
hydration of stratum corneum like xerosis, wind, soap, and sun-
light (Inanir et al., 2002; O’Farrell, 1956; Zaynoun et al., 1983).
In the initial series of PPA, 65% of the patients had an
accompanying dermatophyte infection (tinea capitis and tinea
faciale) and 30% had a concurrent PA. Dhar et al. reported a
case of PPA that was associated with classic PA lesions. In our
patient, PPA was not associated with dermatophyte infection
or PA. In addition, examination of all the PPA lesions up-
to-date, including our case, did not reveal any fungal element
(du Toit and Jordaan, 1993; Dhar et al., 1995).
PPA is similar to classic PA in being usually asymptomatic.
The most common patient complaints are mild pruritus and
unattractive appearance due to lesions on the face (du Toit
and Jordaan, 1993; Dhar et al., 1995).
Clinically, PA usually starts as a pink macule with an ele-
vated border. After several weeks, it fades, leaving a hypopig-
mented spot with a powdery white scale (Hacker, 1996). These
spots will progress to smooth pale patches that can persist
from 6 months to 7 years (Bassaly et al., 1963). Most lesions
appear on the face but can also affect the upper extremities
and occasionally the lower extremities (Wells et al., 1960).
On the other hand, PPA appears as a scaly bluish hyperpig-
mented patch surrounded by a hypopigmented rim of variable
width (du Toit and Jordaan, 1993; Dhar et al., 1995). Almost
all patients, including our patient, had lesions on the face with
involvement of the forehead and cheeks being the most com-
mon. Concomitant extrafacial involvement is rare (du Toit
and Jordaan, 1993).
The variable histology of PA may be attributable to the
stage of PA (Hacker, 1996). Early on, there is follicular plug-
ging and atrophic sebaceous glands. Perivascular lymphocytic
inﬁltrates and edema are evident in the dermis. The intermedi-
ate stage is characterized by damage to the hair follicle and
spongiotic edema. Late stage PA shows a pattern typical of
chronic dermatitis and irregular melanization (Lin and Janni-
ger, 2005).
Analysis of PPA lesions, revealed a subacute dermatitis
with pigment incontinence. The bluish color ascribed to the
presence of dermal melanin is not a ﬁnding in classic PA (du
Toit and Jordaan, 1993). As with the previously reported
cases, our patient did not show any clinical or histopathologic
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hagen and Koten (1979).
Treatment for patients with PA revolves around assuring
them that the disorder is self-limiting and not dangerous (Mar-
tin et al., 1990). Clinicians usually recommend measures such
as decreasing sun exposure, regular use of sunscreen and lubri-
cants, and reducing the frequency and temperature of baths
(Zaynoun et al., 1986). Topical 1% hydrocortisone cream
can be helpful in cases with inﬂammation (Lin and Janniger,
2005).
All the patients of Du Toit et al. series, received 1% hydro-
cortisone cream twice a day for the PPA lesions and only 46%
of them used oral griseofulvin (10 mg/kg/day) for the concur-
rent dermatophyte infection with complete resolution of all le-
sions (du Toit and Jordaan, 1993). Another PPA case treated
with topical clobetasone – 17 – butyrate applied twice a day
for 8–10 weeks showed total response (Dhar et al., 1995).
Our patient’s patches cleared after twice a day treatment with
1% hydrocortisone cream for 12 weeks.
From the initial series and the subsequent reports – including
our patient – one can conclude that PPA is a rare under-reported
variant of PA. The relation between PPA and dermatophyte
infection is possible but questionable. All lesions of PPA have
been treated and responded well to topical corticosteroid treat-
ment with variable durations. The rule of griseofulvin in the
improvement of PPA lesions either through anti-fungal or
anti-inﬂammatory action is subjected to further well-structured
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